Gadolinium Lawyer

The U.S. Food and Drug Administration (FDA) have asked manufacturers of all gadolinium-based contrast agents to include a new boxed warning on the product labeling. These agents are used to enhance the quality of magnetic resonance imaging (MRI).The warning states that patients with severe kidney insufficiency are at risk for developing a debilitating, and a […]

[Read more →]

Although the issues surrounding gadolinium’s presence in contrasting agents for MRI’s and MRA’s has been in the news in one form or another for quite some time, now comes word that medical publications are beginning to take notice.  The latest example was published on eMaxHealth.com, a widely-read health-driven newsletter, which published a story regarding the […]

[Read more →]

As news regarding the dangers of gadolinium continues to hit the wires, an interesting piece was published just yesterday on Doctor’s Guide, which told the story of how one of the manufacturers of a contrasting agent that contains gadolinium has issued a warning letter to health care professionals regarding the inherent dangers of the substance.
“Manufacturers […]

[Read more →]

Is there any other time this drug gadolinium used other than for a MRI?
******************************************************************
No, it’s primary use is as a constrast agent in MRIs.  To learn more, please contact Gadolinium Lawyers at Williams Kherkher at 1.800.220.9341.

[Read more →]

While kidney patients inherently face a host of medically debilitating issues, a new study, as reported by the United Press International, suggests that those patients on dialysis face an increased risk of a rare and devastating  disease – nephrogenic systemic fibrosis, or NSF.
The study, conducted by researchers at Wake Forest University Baptist Medical Center in […]

[Read more →]